Key facts
- This page summarizes John Soriano's Form 4 filing for INSMED Inc (INSM).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 09 Sep 2021, 16:10.
John Soriano - 07 Sep 2021 Form 4 Insider Report for INSMED Inc (INSM)
- Reporting relationship
- Chief Compliance Officer
- Issuer ticker
- INSM
- Reported as of
- 07 Sep 2021
- Net transaction value
- -$247,917
- SEC form
- 4
- Accepted by SEC
- 09 Sep 2021, 16:10:41 UTC
- Prior SEC filing
- 18 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Soriano
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John Soriano filed Form 4 for INSMED Inc (INSM) on 09 Sep 2021.
Change
- Previous filing in this sequence was filed on 18 May 2021.
- Current net transaction value: -$247,917.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
INSM
transaction
Common Stock
Options Exercise
- Transaction value
- $241,325
- Shares
- +17,349
- Change %
- +49%
- Price
- $13.91
- Shares after
- 52,553
- Date
- 07 Sep 2021
- Ownership
- Direct
INSM
transaction
Common Stock
Sale
- Transaction value
- $489,242
- Shares
- -17,349
- Change %
- -33%
- Price
- $28.20
- Shares after
- 35,204
- Date
- 07 Sep 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
INSM
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -17,349
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 52,046
- Date
- 07 Sep 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,349
- Exercise price
- $13.91
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This is the weighted average sales price representing the shares sold at prices ranging from $28.11 to $28.37 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Footnote F2
The options become exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.